Literature DB >> 17377811

D2-40 labeling in lymphangiomyoma/lymphangiomyomatosis of the soft tissue: further evidence of lymphangiogenic tumor histogenesis.

Torsten Hansen1, Kathrin Katenkamp, Fernando Bittinger, C James Kirkpatrick, Detlef Katenkamp.   

Abstract

We examined ten cases of extrapulmonary lymphangioleiomyoma/lymphangioleiomyomatosis (LAM; all patients female; median age 46.5 years) for immunohistochemical labeling with a monoclonal antibody against podoplanin (D2-40), which is specific for lymphatic endothelial lining. We found positive staining in thin-wall branching vessels reflecting the lymphatic nature of tumor vessels in all cases tested. In contrast, perivascular (HMB-45 positive) myoid cells were not detected by D2-40. The D2-40 labeling confirms the current concept of lymphangiogenic origin of the tumor vessels in LAM. In addition, this study makes a further contribution to the immunohistochemical mapping of this antibody in vascular tumors. Finally, the use of this commercially available antibody provides an additional help in the differential diagnosis of LAM from other soft tissue tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377811     DOI: 10.1007/s00428-007-0376-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  Lymphangioma and lymphangiomyomatosis--the same lesion?

Authors:  Stanisław Betlejewski; Danuta Burduk; Jacenty Szukalski
Journal:  Otolaryngol Pol       Date:  2004

2.  D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma.

Authors:  Larisa V Debelenko; Antonio R Perez-Atayde; John B Mulliken; Marilyn G Liang; Tonora H Archibald; Harry P W Kozakewich
Journal:  Mod Pathol       Date:  2005-11       Impact factor: 7.842

3.  Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.

Authors:  Harriette J Kahn; Denis Bailey; Alexander Marks
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

Review 4.  PEComa: what do we know so far?

Authors:  J L Hornick; C D M Fletcher
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

Review 5.  Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.

Authors:  K Matsui; A Tatsuguchi; J Valencia; Z x Yu; J Bechtle; M B Beasley; N Avila; W D Travis; J Moss; V J Ferrans
Journal:  Hum Pathol       Date:  2000-10       Impact factor: 3.466

6.  Podoplanin: a novel diagnostic immunohistochemical marker.

Authors:  Nelson G Ordóñez
Journal:  Adv Anat Pathol       Date:  2006-03       Impact factor: 3.875

7.  Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.

Authors:  Marc P Pusztaszeri; Walter Seelentag; Fred T Bosman
Journal:  J Histochem Cytochem       Date:  2005-10-18       Impact factor: 2.479

8.  Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.

Authors:  Toshio Kumasaka; Kuniaki Seyama; Keiko Mitani; Teruhiko Sato; Sanae Souma; Takashi Kondo; Seiji Hayashi; Masato Minami; Toshimasa Uekusa; Yoshinosuke Fukuchi; Koichi Suda
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

9.  Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas.

Authors:  Folker E Franke; Klaus Steger; Alexander Marks; Heinz Kutzner; Thomas Mentzel
Journal:  J Cutan Pathol       Date:  2004-05       Impact factor: 1.587

10.  [Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology].

Authors:  E Kaiserling
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

View more
  6 in total

1.  Pulmonary lymphangioleiomyomatosis: unusual manifestations of multiple large pulmonary nodules with retroperitoneal lymph node involvement mimicking metastatic malignancy.

Authors:  Hye-Jung Kim; Chang-Hoon Lee; Yong-A Kim; Daehee Han; Hyeon Jong Moon; Hey Won Cheon; Hee Soon Chung; Deog Kyeom Kim
Journal:  BMJ Case Rep       Date:  2009-09-09

2.  Expression of podoplanin in Warthin tumours.

Authors:  Torsten Hansen; C James Kirkpatrick
Journal:  Oral Maxillofac Surg       Date:  2010-12

3.  Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells.

Authors:  Jennifer M Davis; Elizabeth Hyjek; Aliya N Husain; Le Shen; Jennifer Jones; Lucia A Schuger
Journal:  J Histochem Cytochem       Date:  2013-04-22       Impact factor: 2.479

Review 4.  Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.

Authors:  Connie G Glasgow; Souheil El-Chemaly; Joel Moss
Journal:  Eur Respir Rev       Date:  2012-09-01

5.  Immunohistochemical analysis of oral dysplasia: diagnostic assessment by fascin and podoplanin expression.

Authors:  Yumiko Shimamura; Takahiro Abe; Mitsuhiko Nakahira; Tetsuya Yoda; Shin-Ichi Murata; Masashi Sugasawa
Journal:  Acta Histochem Cytochem       Date:  2011-10-14       Impact factor: 1.938

6.  The role of podoplanin in the biology of differentiated thyroid cancers.

Authors:  Magdalena Rudzińska; Damian Gaweł; Justyna Sikorska; Kamila M Karpińska; Mirosław Kiedrowski; Tomasz Stępień; Magdalena Marchlewska; Barbara Czarnocka
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.